Share on (60599720174):

In vitro test for the quantitative determination of gamma-glutamyl transferase in human serum on the above-mentioned clinical chemistry analyzers.




BioSino Bio-Technology & Science Inc. is a high-tech enterprise based on protein industry. Founded by the Chinese Academy of Sciences in 1988,BioSino mainly engages in R&D, production and sales of in vitro diagnostic products. As a leading domestic IVD company with 12 subsidiaries,BioSino has been listed in Hong Kong Stock Exchange since 2006. Its product line-up covers a variety of fields in the IVD industry, including clinical chemistry, immunological diagnostic products, molecular diagnostic products, hematology diagnostic products, medical clinical nutrition diagnostic products and related analytical instruments and raw materials.
In 2011, BioSino Bio-Technology & Science Inc. signed an incorporation agreement with Abbott, the global health care company, allowing Abbott to sell and distribute BioSino clinical chemistry reagents in China. The agreement enables Abbott to provide a more comprehensive clinical chemistry menu to laboratory customers.
Over 500 distributors and retailers form a sales network nationwide covering 75% of the users in the industry. In addition, BioSino has now registered the clinical chemistry reagents in CMDCAS of Canada. The products are now exported to more than forty countries in Asia, Africa, and East European countries.
New products from manufacturers at wholesale prices